Cargando…
Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
BACKGROUND: Many patients in methadone treatment have difficulty achieving or maintaining drug abstinence, and many clinics have policies that lead to discharging these patients. We designed a pilot “Second Chance” (SC) program for patients scheduled to be discharged from other local methadone clini...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669697/ https://www.ncbi.nlm.nih.gov/pubmed/36407024 http://dx.doi.org/10.1177/11782218221138335 |
_version_ | 1784832176887431168 |
---|---|
author | Moses, Tabitha E Rhodes, Gary L Tavakoli, Emytis Christensen, Carl W Amirsadri, Alireza Greenwald, Mark K |
author_facet | Moses, Tabitha E Rhodes, Gary L Tavakoli, Emytis Christensen, Carl W Amirsadri, Alireza Greenwald, Mark K |
author_sort | Moses, Tabitha E |
collection | PubMed |
description | BACKGROUND: Many patients in methadone treatment have difficulty achieving or maintaining drug abstinence, and many clinics have policies that lead to discharging these patients. We designed a pilot “Second Chance” (SC) program for patients scheduled to be discharged from other local methadone clinics to be transferred to our clinic. AIM: Determine whether SC patients’ retention and opioid use is related to physical or mental health conditions, non-opioid substance use, or treatment features. METHODS: From December 2012 to December 2014, this program enrolled 70 patients who were discharged from other clinics in the area; we were their last remaining option for methadone treatment. Unlike the clinic’s standard policies, the treatment focus for SC patients was retention rather than abstinence. This program focused on connection to care (eg, psychiatric services) and enabled patients to continue receiving services despite ongoing substance use. Each patient was assessed at treatment entry and followed until June 2016 to evaluate outcomes. RESULTS: SC patients receiving disability benefits (n = 37) vs. non-disabled (n = 33) had significantly (P < .05) higher rates of current DSM-IV Axis I psychiatric diagnosis (97% vs 70%), prescriptions for opioids (84% vs 55%) and benzodiazepines (65% vs 27%), and higher methadone doses at admission (58 vs 46 mg) but did not differ significantly in rates of 6-month or 1-year retention (77% and 56%, respectively) or all-drug use (39% positive urine drug screens). Methadone doses >65 mg predicted significantly longer retention and less opioid use, but these effects were not moderated by baseline characteristics. CONCLUSIONS: Patients in methadone treatment struggling to achieve abstinence may benefit from retention-oriented harm-reduction programs. Higher methadone doses can improve retention and opioid abstinence despite psychiatric comorbidities. Further work is needed to improve program implementation and outcomes in this complex population. |
format | Online Article Text |
id | pubmed-9669697 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-96696972022-11-18 Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program Moses, Tabitha E Rhodes, Gary L Tavakoli, Emytis Christensen, Carl W Amirsadri, Alireza Greenwald, Mark K Subst Abuse Original Research Article BACKGROUND: Many patients in methadone treatment have difficulty achieving or maintaining drug abstinence, and many clinics have policies that lead to discharging these patients. We designed a pilot “Second Chance” (SC) program for patients scheduled to be discharged from other local methadone clinics to be transferred to our clinic. AIM: Determine whether SC patients’ retention and opioid use is related to physical or mental health conditions, non-opioid substance use, or treatment features. METHODS: From December 2012 to December 2014, this program enrolled 70 patients who were discharged from other clinics in the area; we were their last remaining option for methadone treatment. Unlike the clinic’s standard policies, the treatment focus for SC patients was retention rather than abstinence. This program focused on connection to care (eg, psychiatric services) and enabled patients to continue receiving services despite ongoing substance use. Each patient was assessed at treatment entry and followed until June 2016 to evaluate outcomes. RESULTS: SC patients receiving disability benefits (n = 37) vs. non-disabled (n = 33) had significantly (P < .05) higher rates of current DSM-IV Axis I psychiatric diagnosis (97% vs 70%), prescriptions for opioids (84% vs 55%) and benzodiazepines (65% vs 27%), and higher methadone doses at admission (58 vs 46 mg) but did not differ significantly in rates of 6-month or 1-year retention (77% and 56%, respectively) or all-drug use (39% positive urine drug screens). Methadone doses >65 mg predicted significantly longer retention and less opioid use, but these effects were not moderated by baseline characteristics. CONCLUSIONS: Patients in methadone treatment struggling to achieve abstinence may benefit from retention-oriented harm-reduction programs. Higher methadone doses can improve retention and opioid abstinence despite psychiatric comorbidities. Further work is needed to improve program implementation and outcomes in this complex population. SAGE Publications 2022-11-15 /pmc/articles/PMC9669697/ /pubmed/36407024 http://dx.doi.org/10.1177/11782218221138335 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Article Moses, Tabitha E Rhodes, Gary L Tavakoli, Emytis Christensen, Carl W Amirsadri, Alireza Greenwald, Mark K Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program |
title | Predictors of Retention and Drug Use Among Patients With Opioid Use
Disorder Transferred to a Specialty “Second Chance” Methadone
Program |
title_full | Predictors of Retention and Drug Use Among Patients With Opioid Use
Disorder Transferred to a Specialty “Second Chance” Methadone
Program |
title_fullStr | Predictors of Retention and Drug Use Among Patients With Opioid Use
Disorder Transferred to a Specialty “Second Chance” Methadone
Program |
title_full_unstemmed | Predictors of Retention and Drug Use Among Patients With Opioid Use
Disorder Transferred to a Specialty “Second Chance” Methadone
Program |
title_short | Predictors of Retention and Drug Use Among Patients With Opioid Use
Disorder Transferred to a Specialty “Second Chance” Methadone
Program |
title_sort | predictors of retention and drug use among patients with opioid use
disorder transferred to a specialty “second chance” methadone
program |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669697/ https://www.ncbi.nlm.nih.gov/pubmed/36407024 http://dx.doi.org/10.1177/11782218221138335 |
work_keys_str_mv | AT mosestabithae predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram AT rhodesgaryl predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram AT tavakoliemytis predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram AT christensencarlw predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram AT amirsadrialireza predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram AT greenwaldmarkk predictorsofretentionanddruguseamongpatientswithopioidusedisordertransferredtoaspecialtysecondchancemethadoneprogram |